Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

BACKGROUND: Indacaterol is a novel, once-daily, inhaled, long-acting b2-agonist for patients with chronic obstructive pulmonary disease (COPD). The study objective was to evaluate the efficacy of indacaterol on quality of life and pulmonary function in patients with COPD in a real-world setting, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno, Takeshi, Wada, Shota, Hanada, Souichirou, Sawaguchi, Hirochiyo, Muraki, Masato, Tohda, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904808/
https://www.ncbi.nlm.nih.gov/pubmed/24489464
http://dx.doi.org/10.2147/COPD.S56777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904808/
https://www.ncbi.nlm.nih.gov/pubmed/24489464
http://dx.doi.org/10.2147/COPD.S56777

Ejemplares similares